{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:34:59Z","timestamp":1771054499936,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1007\/s11894-003-0011-0","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T20:47:19Z","timestamp":1179607639000},"page":"63-70","source":"Crossref","is-referenced-by-count":32,"title":["Vascular liver diseases"],"prefix":"10.1007","volume":"5","author":[{"given":"Laurie D.","family":"DeLeve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.510280505","volume":"28","author":"K Okuda","year":"1998","unstructured":"Okuda K, Kage M, Shrestha SM: Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 1998, 28:1191\u20131198.","journal-title":"Hepatology"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","volume":"31","author":"MH Denninger","year":"2000","unstructured":"Denninger MH, Chait Y, Casadevall N, et al.: Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000, 31:587\u2013591. One of two pivotal studies characterizing the prothrombotic risk factors for BCS and portal vein thrombosis.","journal-title":"Hepatology"},{"key":"11_CR3","first-page":"2364","volume":"96","author":"HL Janssen","year":"2000","unstructured":"Janssen HL, Meinardi JR, Vleggaar FP, et al.: Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000, 96:2364\u20132368. A second important study characterizing the prothrombotic risk factors for BCS and portal vein thrombosis.","journal-title":"Blood"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199905203402007","volume":"340","author":"RD Rosenberg","year":"1999","unstructured":"Rosenberg RD, Aird WC: Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999, 340:1555\u20131564. The authors discuss the novel concept that endothelial cell heterogeneity is responsible for determining why systemic hypercoagulable states target specific vascular beds rather than causing thrombosis in random locations.","journal-title":"N Engl J Med"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1051-0443(99)70118-1","volume":"10","author":"RK Ryu","year":"1999","unstructured":"Ryu RK, Durham JD, Krysl J, et al.: Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol 1999, 10:799\u2013805.","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR6","first-page":"603","volume":"94","author":"DR Ganger","year":"1999","unstructured":"Ganger DR, Klapman JB, McDonald V, et al.: Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis. Am J Gastroenterol 1999, 94:603\u2013608.","journal-title":"Am J Gastroenterol"},{"key":"11_CR7","first-page":"511","volume":"166","author":"DA Campbell Jr.","year":"1988","unstructured":"Campbell DA, Jr., Rolles K, Jamieson N, et al.: Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet 1988, 166:511\u2013518.","journal-title":"Surg Gynecol Obstet"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000658-200104000-00007","volume":"233","author":"DP Slakey","year":"2001","unstructured":"Slakey DP, Klein AS, Venbrux AC, et al.: Budd-Chiari syndrome: current management options. Ann Surg 2001, 233:522\u2013527.","journal-title":"Ann Surg"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9343(00)00449-6","volume":"109","author":"A Tefferi","year":"2000","unstructured":"Tefferi A, Solberg LA, Silverstein MN: A clinical update in polycythemia vera and essential thrombocythemia. Am J Med 2000, 109:141\u2013149. Primary myeloproliferative disorders predispose to BCS, portal vein thrombosis, NRH, and peliosis hepatis. This review of two of the three chronic myeloproliferative disorders provides valuable information on clinical management.","journal-title":"Am J Med"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","volume":"332","author":"S Cortelazzo","year":"1995","unstructured":"Cortelazzo S, Finazzi G, Ruggeri M, et al.: Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995, 332:1132\u20131136.","journal-title":"N Engl J Med"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0168-8278(00)80259-7","volume":"32","author":"D Valla","year":"2000","unstructured":"Valla D, Condat B: Portal vein thrombosis in adults: pathophysiology, pathogenesis, and management. J Hepatol 2000, 32:865\u2013871.","journal-title":"J Hepatol"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","volume":"120","author":"B Condat","year":"2001","unstructured":"Condat B, Pesslore F, Hillaire S, et al.: Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001, 120:490\u2013497.","journal-title":"Gastroenterology"},{"key":"11_CR13","first-page":"285","volume":"57","author":"G Bras","year":"1954","unstructured":"Bras G, Jeliffe DB, Stuart KL: Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica. Arch Pathol 1954, 57:285\u2013300.","journal-title":"Arch Pathol"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, et al.: Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994, 19:1171\u20131181.","journal-title":"Hepatology"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","volume":"29","author":"LD DeLeve","year":"1999","unstructured":"DeLeve LD, McCuskey RS, Wang X, et al.: Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999, 29:1779\u20131781.","journal-title":"Hepatology"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, McDonald GB: Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venoocclusive disease). Semin Liver Dis 2002, 22:27\u201342. This review article was cowritten by a basic investigator, a pathologist, and a clinical investigator. The range in expertise of the authors permits a comprehensive discussion of sinusoidal obstruction syndrome.","journal-title":"Semin Liver Dis"},{"key":"11_CR17","first-page":"1261","volume":"268","author":"LD DeLeve","year":"1994","unstructured":"DeLeve LD: Dacarbazine toxicity in murine liver cells: a novel model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther 1994, 268:1261\u20131270.","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","volume":"23","author":"LD DeLeve","year":"1996","unstructured":"DeLeve LD, Wang X, Kuhlenkamp JF, et al.: Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venooclusive disease. Hepatology 1996, 23:589\u2013599.","journal-title":"Hepatology"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.510240414","volume":"24","author":"LD DeLeve","year":"1996","unstructured":"DeLeve LD: Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology 1996, 24:830\u2013837.","journal-title":"Hepatology"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/0016-5085(80)90911-7","volume":"79","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, McDonald GB, Matthews D, et al.: An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1980, 79:1178\u20131191.","journal-title":"Gastroenterology"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, et al.: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993, 118:255\u2013267.","journal-title":"Ann Intern Med"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9343(86)90266-4","volume":"81","author":"BJ Rollins","year":"1986","unstructured":"Rollins BJ: Hepatic veno-occlusive disease. Am J Med 1986, 81:297\u2013306","journal-title":"Am J Med"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschorner WE, et al.: Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987, 44:778\u2013783.","journal-title":"Transplantation"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1083-8791(99)70006-6","volume":"5","author":"JL Lee","year":"1999","unstructured":"Lee JL, Gooley T, Bensinger W, et al.: Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. Biol Blood Marrow Transpl 1999, 5:306\u2013315.","journal-title":"Biol Blood Marrow Transpl"},{"key":"11_CR25","first-page":"135","volume":"10","author":"V M\u2019eresse","year":"1992","unstructured":"M\u2019eresse V, Hartmann O, Vassal G, et al.: Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transpl 1992, 10:135\u2013141.","journal-title":"Bone Marrow Transpl"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003088-200039020-00005","volume":"39","author":"JS McCune","year":"2000","unstructured":"McCune JS, Gibbs JP, Slattery JT: Plasma concentration monitoring of busulfan: Does it improve clinical outcome? Clin Pharmacokinet 2000, 39:155\u2013165.","journal-title":"Clin Pharmacokinet"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","volume":"89","author":"SI Bearman","year":"1997","unstructured":"Bearman SI, Lee JL, Bar\u2019on AE, et al.: Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 1997, 89:1501\u20131506.","journal-title":"Blood"},{"key":"11_CR28","first-page":"118","volume":"50","author":"D Azoulay","year":"1998","unstructured":"Azoulay D, Castaing D, Lemoine A, et al.: Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt. Clin Nephrol 1998, 50:118\u2013122.","journal-title":"Clin Nephrol"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bmt.1701654","volume":"23","author":"S Kulkarni","year":"1999","unstructured":"Kulkarni S, Rodriguez M, Lafuente A, et al.: Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD). Bone Marrow Transpl 1999, 23:803\u2013807.","journal-title":"Bone Marrow Transpl"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1702386","volume":"25","author":"D Azoulay","year":"2000","unstructured":"Azoulay D, Castaing D, Lemoine A, et al.: Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transpl 2000, 25:987\u2013992.","journal-title":"Bone Marrow Transpl"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/jlts.2001.0070154","volume":"7","author":"P Rajvanshi","year":"2001","unstructured":"Rajvanshi P, McDonald GB. Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease. Liver Transplant 2001; 7:154.","journal-title":"Liver Transplant"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1034\/j.1600-0676.2001.210105.x","volume":"21","author":"T Zenz","year":"2001","unstructured":"Zenz T, R\u00f6ssle M, Bertz H, et al.: Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation-role of transjugular intrahepatic portosystemic shunt (TIPS). Liver 2001, 21:31\u201336.","journal-title":"Liver"},{"key":"11_CR33","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W, et al.: Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998, 92:3599\u20133604.","journal-title":"Blood"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0360-3016(88)90009-0","volume":"14","author":"G Ganem","year":"1988","unstructured":"Ganem G, Saint-Marc Girardin MF, Kuentz M, et al.: Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Biol Phys 1988, 14:879\u2013884.","journal-title":"Int J Radiat Biol Phys"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00007890-198506000-00005","volume":"36","author":"GB McDonald","year":"1985","unstructured":"McDonald GB, Sharma P, Matthews DE, et al.: The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation. Transplantation 1985, 36:603\u2013608.","journal-title":"Transplantation"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI: The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995, 85:3005\u20133020.","journal-title":"Blood"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","volume":"11","author":"IR Wanless","year":"1990","unstructured":"Wanless IR: Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990, 11:787\u2013797.","journal-title":"Hepatology"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00004836-199008000-00023","volume":"12","author":"Y Nakanuma","year":"1990","unstructured":"Nakanuma Y: Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990, 12:460\u2013465.","journal-title":"J Clin Gastroenterol"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005792-198009000-00004","volume":"59","author":"IR Wanless","year":"1980","unstructured":"Wanless IR, Godwin TA, Allen F, et al.: Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine 1980, 59:367\u2013379.","journal-title":"Medicine"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.510260214","volume":"26","author":"K Shimamatsu","year":"1997","unstructured":"Shimamatsu K, Wanless IR: Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997, 26:343\u2013350.","journal-title":"Hepatology"},{"key":"11_CR41","first-page":"256","volume":"83","author":"NY Haboubi","year":"1988","unstructured":"Haboubi NY, Ali HH, Whitwell HL, et al.: Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988, 83:256\u2013261.","journal-title":"Am J Gastroenterol"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/hep.1840090317","volume":"9","author":"DC Snover","year":"1989","unstructured":"Snover DC, Weisdorf S, Bloomer J, et al.: Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 1989, 9:443\u2013448.","journal-title":"Hepatology"},{"key":"11_CR43","first-page":"866","volume":"116","author":"SS Leong","year":"1992","unstructured":"Leong SS, Cazen RA, Yu GS, et al.: Abdominal visceral peliosis associated with bacillary angiomatosis: ultrastructural evidence of endothelial destruction by bacilli. Arch Pathol Lab Med 1992, 116:866\u2013871.","journal-title":"Arch Pathol Lab Med"},{"key":"11_CR44","first-page":"38","volume":"131","author":"JY Scoazec","year":"1988","unstructured":"Scoazec JY, Marche C, Girard PM, et al.: Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV): an ultrastructural study. Am J Pathol 1988, 131:38\u201347.","journal-title":"Am J Pathol"},{"key":"11_CR45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00227347","volume":"70","author":"S Goerdt","year":"1992","unstructured":"Goerdt S, Sorg C: Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders. Clin Invest 1992, 70:89\u201398.","journal-title":"Clin Invest"},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-2007-1007173","volume":"18","author":"LD DeLeve","year":"1998","unstructured":"DeLeve LD: Glutathione defense in non-parenchymal cells. Semin Liver Dis 1998, 18:403\u2013413.","journal-title":"Semin Liver Dis"},{"key":"11_CR47","first-page":"349","volume":"114","author":"ES Zafrani","year":"1984","unstructured":"Zafrani ES, Cazier A, Baudelot AM, et al.: Ultrastructural lesions of the liver in human peliosis: a report of 12 cases. Am J Pathol 1984, 114:349\u2013358.","journal-title":"Am J Pathol"},{"key":"11_CR48","first-page":"593","volume-title":"Drug-induced Liver Disease","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD: Cancer chemotherapy. In Drug-induced Liver Disease.Edited by Kaplowitz N, DeLeve LD. New York: Marcel Dekker;2002:593\u2013632."},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9343(00)00461-7","volume":"109","author":"RK Seeto","year":"2000","unstructured":"Seeto RK, Fenn B, Rockey DC: Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000, 109:109\u2013113.","journal-title":"Am J Med"},{"key":"11_CR50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, et al.: Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis,incidence and predisposing factors. Hepatology 1984, 4:116\u2013122.","journal-title":"Hepatology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-003-0011-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-003-0011-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-003-0011-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T05:40:24Z","timestamp":1587534024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-003-0011-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11894-003-0011-0","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}